Code | 02726 | ||||||||||
MA number | EU/1/98/063/011 | ||||||||||
Product Form: | sol inj 1x0,5 ml/22 µg (pero napln.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Merck Europe B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 18 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 02.06.2010 |
SmPC + PL: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 19.06.2018 |